Platinum is essential in neoadjuvant treatment of triple negative breast cancer: A network meta-analysis

被引：0
|
作者：
Li, Junjie
Chen, Li
Tan, Wei
Qi, Fang
Zhang, Yang
Wang, Zhonghua
Shao, Zhimin
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-12-19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-12-19
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
    Fausto Petrelli
    Andrea Coinu
    Karen Borgonovo
    Mary Cabiddu
    Mara Ghilardi
    Veronica Lonati
    Sandro Barni
    Breast Cancer Research and Treatment, 2014, 144 : 223 - 232
  • [22] ErbB inhibitors as neoadjuvant therapy for triple-positive breast cancer: a network meta-analysis
    Chen, Danxiang
    Jin, Lingli
    Xu, Yiying
    Bhandari, Adheesh
    Wang, Ouchen
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (11): : 12129 - 12140
  • [23] Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
    Petrelli, Fausto
    Bertaglia, Valentina
    Parati, Maria Chiara
    Borgonovo, Karen
    De Silva, Pushpamali
    Luciani, Andrea
    Novello, Silvia
    Scartozzi, Mario
    Emens, Leisha A.
    Solinas, Cinzia
    BREAST, 2023, 67 : 8 - 13
  • [24] A Bayesian network meta-analysis of the efficacy of targeted therapies and chemotherapy for treatment of triple-negative breast cancer
    Chen, Huihui
    Lu, Wei
    Zhang, Yixin
    Zhu, Xuan
    Zhou, Jiaojiao
    Chen, Yiding
    CANCER MEDICINE, 2019, 8 (01): : 383 - 399
  • [25] Neoadjuvant and adjuvant treatment for triple negative breast cancer
    Carey, L.
    BREAST, 2021, 56 : S9 - S10
  • [26] Both Carboplatin and Bevacizumab Improve Pathological Complete Remission Rate in Neoadjuvant Treatment of Triple Negative Breast Cancer: A Meta-Analysis
    Chen, Xiao-song
    Yuan, Ying
    Garfield, David H.
    Wu, Jia-yi
    Huang, Ou
    Shen, Kun-wei
    PLOS ONE, 2014, 9 (09):
  • [27] Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis
    Olga Caramelo
    Cristina Silva
    Francisco Caramelo
    Cristina Frutuoso
    Leonor Pinto
    Teresa Almeida-Santos
    Hereditary Cancer in Clinical Practice, 20
  • [28] Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis
    Caramelo, Olga
    Silva, Cristina
    Caramelo, Francisco
    Frutuoso, Cristina
    Pinto, Leonor
    Almeida-Santos, Teresa
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [29] Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis
    Saleh, Ramy R.
    Nadler, Michelle B.
    Desnoyers, Alexandra
    Meti, Nicholas
    Fazelzad, Rouhi
    Amir, Eitan
    CANCER TREATMENT REVIEWS, 2021, 100
  • [30] Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis
    Saleh, Ramy
    Nadler, Michelle B.
    Desnoyers, Alexandra
    Fazelzad, Rouhi
    Amir, Eitan
    CANCER RESEARCH, 2020, 80 (04)
12345